The common clinical concerns as to when to continue, hold, and resume antithrombotic agents during acute GI bleeds and elective endoscopy have been allayed by new evidence-based guidelines.
Direct oral anticoagulants are more effective than dalteparin in reducing the risk of thrombosis recurrence without significantly increasing the risk of major bleeding.
At IDF 2021, two speakers presented different views on the benefit-risk balance of cardiovascular protection versus bleeding risk in those who haven t already had a vascular event.